Q1 EPS Forecast for Tenet Healthcare Reduced by Analyst

Tenet Healthcare Co. (NYSE:THC) – Equities research analysts at Zacks Research lowered their Q1 2026 earnings per share (EPS) estimates for Tenet Healthcare in a research note issued to investors on Wednesday, March 26th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $3.43 per share for the quarter, down from their prior forecast of $3.45. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q4 2026 earnings at $3.56 EPS and FY2026 earnings at $13.40 EPS.

A number of other research firms have also commented on THC. Truist Financial reduced their price objective on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a $175.00 price objective on shares of Tenet Healthcare in a research note on Tuesday, December 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $177.00 target price on shares of Tenet Healthcare in a research note on Thursday, February 13th. KeyCorp lowered their price target on Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Finally, TD Cowen assumed coverage on Tenet Healthcare in a research report on Wednesday, February 26th. They set a “buy” rating and a $175.00 price objective for the company. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $166.41.

Tenet Healthcare Trading Down 0.9 %

Shares of NYSE THC opened at $133.17 on Friday. The business has a fifty day simple moving average of $132.43 and a 200-day simple moving average of $142.42. The company has a market cap of $12.67 billion, a price-to-earnings ratio of 4.13, a P/E/G ratio of 1.02 and a beta of 2.06. Tenet Healthcare has a 12 month low of $90.03 and a 12 month high of $171.20. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25.

Tenet Healthcare (NYSE:THC) last released its earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.

Hedge Funds Weigh In On Tenet Healthcare

Several large investors have recently made changes to their positions in THC. New Wave Wealth Advisors LLC bought a new position in Tenet Healthcare during the fourth quarter worth $343,000. Swedbank AB lifted its stake in shares of Tenet Healthcare by 100.0% in the fourth quarter. Swedbank AB now owns 40,000 shares of the company’s stock valued at $5,049,000 after buying an additional 20,000 shares during the period. Signet Financial Management LLC bought a new stake in shares of Tenet Healthcare in the fourth quarter valued at about $1,526,000. China Universal Asset Management Co. Ltd. acquired a new position in Tenet Healthcare in the 4th quarter valued at approximately $410,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Tenet Healthcare in the 4th quarter valued at approximately $5,892,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the business’s stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the transaction, the director now owns 27,378 shares of the company’s stock, valued at $3,434,022.54. The trade was a 25.81 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.93% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.